Key facts
- This page summarizes Mario Gargiulo's Form 4 filing for Catalent, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 May 2023, 18:58.
Mario Gargiulo - 01 May 2023 Form 4 Insider Report for Catalent, Inc.
- Reporting relationship
- SVP, Ops, Biologics Europe
- Issuer ticker
- N/A
- Reported as of
- 01 May 2023
- Net transaction value
- -$33,805
- SEC form
- 4
- Accepted by SEC
- 03 May 2023, 18:58:00 UTC
- Prior SEC filing
- 26 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Fallone, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mario Gargiulo filed Form 4 for Catalent, Inc. on 03 May 2023.
Change
- Previous filing in this sequence was filed on 26 Aug 2022.
- Current net transaction value: -$33,805.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CTLT
transaction
Common Stock
Sale
- Transaction value
- $33,805
- Shares
- -678
- Change %
- -11%
- Price
- $49.86
- Shares after
- 5,676
- Date
- 01 May 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Mario Gargiulo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
Footnote F2
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $49.71 to $50.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
Includes restricted stock units.